DE60029110D1 - Verfahren zur identifizierung neuartiger gene, die bei der regulation der angiogenese einer rolle spielen, analyse dieser gene sowie ihre verwendung zu therapeutischen zwecken - Google Patents

Verfahren zur identifizierung neuartiger gene, die bei der regulation der angiogenese einer rolle spielen, analyse dieser gene sowie ihre verwendung zu therapeutischen zwecken

Info

Publication number
DE60029110D1
DE60029110D1 DE60029110T DE60029110T DE60029110D1 DE 60029110 D1 DE60029110 D1 DE 60029110D1 DE 60029110 T DE60029110 T DE 60029110T DE 60029110 T DE60029110 T DE 60029110T DE 60029110 D1 DE60029110 D1 DE 60029110D1
Authority
DE
Germany
Prior art keywords
angiogenesis
genes
condition
messenger rnas
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029110T
Other languages
English (en)
Other versions
DE60029110T2 (de
Inventor
Salman Al-Mahmood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENE SIGNAL INT SA
Original Assignee
GENE SIGNAL INT SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GENE SIGNAL INT SA filed Critical GENE SIGNAL INT SA
Publication of DE60029110D1 publication Critical patent/DE60029110D1/de
Application granted granted Critical
Publication of DE60029110T2 publication Critical patent/DE60029110T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60029110T 1999-09-21 2000-09-20 Verfahren zur identifizierung neuartiger gene, die bei der regulation der angiogenese einer rolle spielen, analyse dieser gene sowie ihre verwendung zu therapeutischen zwecken Expired - Lifetime DE60029110T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9911790A FR2798674B1 (fr) 1999-09-21 1999-09-21 Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques
FR9911790 1999-09-21
PCT/FR2000/002607 WO2001021831A1 (fr) 1999-09-21 2000-09-20 Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques

Publications (2)

Publication Number Publication Date
DE60029110D1 true DE60029110D1 (de) 2006-08-10
DE60029110T2 DE60029110T2 (de) 2007-02-01

Family

ID=9550080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029110T Expired - Lifetime DE60029110T2 (de) 1999-09-21 2000-09-20 Verfahren zur identifizierung neuartiger gene, die bei der regulation der angiogenese einer rolle spielen, analyse dieser gene sowie ihre verwendung zu therapeutischen zwecken

Country Status (10)

Country Link
US (1) US6716585B2 (de)
EP (1) EP1214452B1 (de)
JP (1) JP2003515318A (de)
AT (1) ATE331812T1 (de)
AU (1) AU7529000A (de)
CA (1) CA2385697A1 (de)
DE (1) DE60029110T2 (de)
ES (1) ES2267566T3 (de)
FR (1) FR2798674B1 (de)
WO (1) WO2001021831A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062296A2 (en) 2001-02-02 2002-08-15 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
NZ554534A (en) * 2001-09-27 2008-10-31 Bionomics Ltd DNA sequences for human angiogenesis genes
FR2836687A1 (fr) * 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
FR2837391B1 (fr) * 2002-03-22 2007-04-20 Gene Signal Genes regulateurs de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
US7803906B2 (en) 2002-03-22 2010-09-28 Gene Signal International Sa Composition comprising an angiogenesis related protein
FR2843753A1 (fr) * 2003-06-20 2004-02-27 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
FR2880631A1 (fr) * 2005-01-10 2006-07-14 Gene Signal Genes impliques dans la regularisation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
US8742067B2 (en) 2007-05-16 2014-06-03 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM425294A0 (en) * 1994-03-04 1994-03-31 Australian National University, The In-vitro angiogenesis assay
CA2256481A1 (en) * 1996-05-31 1997-12-04 The National American Red Cross Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
US20020055099A1 (en) * 1999-03-15 2002-05-09 Paul B. Fisher Sequential cdna library and uses thereof
US20020015970A1 (en) * 1999-08-11 2002-02-07 Richard Murray Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators
JP2003525595A (ja) * 1999-11-01 2003-09-02 キュラゲン コーポレイション 脈管形成に含まれる差動発現遺伝子、それにコードされるポリペプチド、及びそれを用いた方法

Also Published As

Publication number Publication date
FR2798674B1 (fr) 2004-01-30
AU7529000A (en) 2001-04-24
ATE331812T1 (de) 2006-07-15
WO2001021831A1 (fr) 2001-03-29
EP1214452A1 (de) 2002-06-19
JP2003515318A (ja) 2003-05-07
FR2798674A1 (fr) 2001-03-23
ES2267566T3 (es) 2007-03-16
CA2385697A1 (fr) 2001-03-29
EP1214452B1 (de) 2006-06-28
US6716585B2 (en) 2004-04-06
DE60029110T2 (de) 2007-02-01
US20030059796A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
Wathlet et al. Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients
Tomkins et al. Control of Specific Gene Expression in Higher Organisms: Expression of mammalian genes may be controlled by repressors acting on the translation of messenger RNA.
Nilsson et al. Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development
Luciano et al. Changes in large-scale chromatin structure and function during oogenesis: a journey in company with follicular cells
DE02708018T1 (de) Neue expressionsvektoren
Kepkova et al. Transcriptomic analysis of in vivo and in vitro produced bovine embryos revealed a developmental change in cullin 1 expression during maternal-to-embryonic transition
DE60029110D1 (de) Verfahren zur identifizierung neuartiger gene, die bei der regulation der angiogenese einer rolle spielen, analyse dieser gene sowie ihre verwendung zu therapeutischen zwecken
NZ538852A (en) Selection and isolation of living cells using mRNA-binding probes
Fujita et al. Mutual enhancement of differentiation of osteoblasts and osteocytes occurs through direct cell–cell contact
Lee et al. Functional role of the bovine oocyte-specific protein JY-1 in meiotic maturation, cumulus expansion, and subsequent embryonic development
Tong et al. Murine osteoclasts and spleen cell polykaryons are distinguished by mRNA phenotyping
Granot et al. Connexin43 in rat oocytes: developmental modulation of its phosphorylation
Argelaguet et al. Single cell multi-omics profiling reveals a hierarchical epigenetic landscape during mammalian germ layer specification
DE60230774D1 (de) Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern
Shur et al. Differential gene expression of cultured human osteoblasts
Hai et al. Chi-miR-370-3p regulates hair follicle morphogenesis of Inner Mongolian cashmere goats
DE69739107D1 (de) Hefevektoren und verfahren für ihre benutzung für die produktion von proteinen.
Pacheco-Trigon et al. Molecular characterization of genomic activities at the onset of zygotic transcription in mammals
CN100519746C (zh) 神经干细胞分化和抑制分化的调控方法
Simon et al. Transient transcriptional activation of gastrin during sodium butyrate-induced differentiation of islet cells
Neves et al. Angiotensin-(1–7) regulates the levels of angiotensin II receptor subtype AT1 mRNA differentially in a strain-specific fashion
BR9708256A (pt) Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo
Manokawinchoke et al. RNA sequencing data of human periodontal ligament cells treated with continuous and intermittent compressive force
Tenenbaum et al. Simultaneous autoradiographic and histochemical analysis of bone formed in vitro.
CN109897854A (zh) 一种双sgRNA位点敲除ZYG11A基因的CRISPR/Cas9系统与应用

Legal Events

Date Code Title Description
8364 No opposition during term of opposition